IndraLab

Statements


MYCBP2 decreases the amount of USP47. 1 / 1
| 1

reach
"PAM treatment also induced beta-catenin translocation and inhibited beta-catenin ubiquitination by activating Akt/GSK-3beta signaling and upregulating USP47 expression."